T Scientific Reports Q1 2026 Operating Loss of KRW 1.05B and Executes Reverse Stock Split

Consolidated Q1 2026 revenue KRW 6.17B, operating loss KRW 1.05B, net loss KRW 1.05B (vs. prior year revenue KRW 7.05B, net loss KRW 3.55B).
Separate Q1 2026 revenue KRW 6.08B, operating loss KRW 0.98B, net loss KRW 0.93B.
Board resolved 5:1 reverse stock split on March 2026, completed April 13. Shares reduced from 71,248,501 to 14,249,700; capital decreased from KRW 35.7B to KRW 7.2B.
Consolidated debt ratio 16.79% (year-end 2025: 19.17%), cash equivalents KRW 9.6B, convertible bonds KRW 90B (conversion price KRW 853, post-split KRW 4,265).
Consolidated retained earnings negative KRW 74.7B, separate negative KRW 75.0B; no dividend paid in last 5 years.
Subsidiaries Hanbitco Korea and Happy Technology have negative net assets of KRW 2.1B and KRW 2.9B respectively.
FVTOCI financial assets (Bithumb Korea etc.) held at KRW 138.5B, representing over 70% of total assets.
Pending damage lawsuit (KRW 0.44B, defendant) lost in first instance; uncertainty remains.